132 related articles for article (PubMed ID: 36752683)
1. Untargeted metabolomics reveals altered branch chain amino acids, glucose and fat metabolism contributing to coronary artery disease among Indian diabetic patients.
Adela R; Kasarla SS; Saquib N; Gupta SK; Bajpai S; Kumar Y; Banerjee SK
Mol Omics; 2023 May; 19(4):321-329. PubMed ID: 36752683
[TBL] [Abstract][Full Text] [Related]
2. Serum Untargeted Metabolomics Reveal Potential Biomarkers of Progression of Diabetic Retinopathy in Asians.
Wang Z; Tang J; Jin E; Zhong Y; Zhang L; Han X; Liu J; Cheng Y; Hou J; Shi X; Qi H; Qian T; Yuan L; Hou X; Yin H; Liang J; Zhao M; Huang L; Qu J
Front Mol Biosci; 2022; 9():871291. PubMed ID: 35755823
[No Abstract] [Full Text] [Related]
3. Altered Asparagine and Glutamate Homeostasis Precede Coronary Artery Disease and Type 2 Diabetes.
Ottosson F; Smith E; Melander O; Fernandez C
J Clin Endocrinol Metab; 2018 Aug; 103(8):3060-3069. PubMed ID: 29788285
[TBL] [Abstract][Full Text] [Related]
4. Small intestine proteomics coupled with serum metabolomics reveal disruption of amino acid metabolism in Chinese hamsters with type 2 diabetes mellitus.
Wang C; Yu J; Zhang R; Wang W; Shi Z; Liu Y; Song G; Wang H; Han N; Huang L; An Y; Tian S; Chen Z
J Proteomics; 2020 Jul; 223():103823. PubMed ID: 32428569
[TBL] [Abstract][Full Text] [Related]
5. Identification of metabolic markers in coronary artery disease using an untargeted LC-MS based metabolomic approach.
Basak T; Varshney S; Hamid Z; Ghosh S; Seth S; Sengupta S
J Proteomics; 2015 Sep; 127(Pt A):169-77. PubMed ID: 25790721
[TBL] [Abstract][Full Text] [Related]
6. Characterizing the metabolic divide: distinctive metabolites differentiating CAD-T2DM from CAD patients.
Liu Y; Liu JE; He H; Qin M; Lei H; Meng J; Liu C; Chen X; Luo W; Zhong S
Cardiovasc Diabetol; 2024 Jan; 23(1):14. PubMed ID: 38184583
[TBL] [Abstract][Full Text] [Related]
7. Serum discrimination and phenotype assessment of coronary artery disease patents with and without type 2 diabetes prior to coronary artery bypass graft surgery.
Hocker JR; Lerner M; Lightfoot SA; Peyton MD; Thompson JL; Deb S; Reinersman M; Hanas RJ; Postier RG; Edil BH; Burkhart HM; Hanas JS
PLoS One; 2020; 15(8):e0234539. PubMed ID: 32756554
[TBL] [Abstract][Full Text] [Related]
8. Serum protein signature of coronary artery disease in type 2 diabetes mellitus.
Adela R; Reddy PNC; Ghosh TS; Aggarwal S; Yadav AK; Das B; Banerjee SK
J Transl Med; 2019 Jan; 17(1):17. PubMed ID: 30674322
[TBL] [Abstract][Full Text] [Related]
9. Lower Vitamin D Metabolites Levels Were Associated With Increased Coronary Artery Diseases in Type 2 Diabetes Patients in India.
Adela R; Borkar RM; Bhandi MM; Vishwakarma G; Reddy PN; Srinivas R; Banerjee SK
Sci Rep; 2016 Nov; 6():37593. PubMed ID: 27883024
[TBL] [Abstract][Full Text] [Related]
10. Metabolic signatures and risk of type 2 diabetes in a Chinese population: an untargeted metabolomics study using both LC-MS and GC-MS.
Lu Y; Wang Y; Ong CN; Subramaniam T; Choi HW; Yuan JM; Koh WP; Pan A
Diabetologia; 2016 Nov; 59(11):2349-2359. PubMed ID: 27514531
[TBL] [Abstract][Full Text] [Related]
11. Serum CXCL16 as a Novel Biomarker of Coronary Artery Disease in Type 2 Diabetes Mellitus: a Pilot Study.
Zhou F; Wang J; Wang K; Zhu X; Pang R; Li X; Zhu G; Pan X
Ann Clin Lab Sci; 2016; 46(2):184-9. PubMed ID: 27098626
[TBL] [Abstract][Full Text] [Related]
12. UHPLC-MS-Based Serum and Urine Metabolomics Reveals the Anti-Diabetic Mechanism of Ginsenoside Re in Type 2 Diabetic Rats.
Wang H; Teng Y; Li S; Li Y; Li H; Jiao L; Wu W
Molecules; 2021 Nov; 26(21):. PubMed ID: 34771066
[No Abstract] [Full Text] [Related]
13. Preliminary serum and fecal metabolomics study of spontaneously diabetic cynomolgus monkeys based on LC-MS/MS.
Tian C; Qiu M; Lv H; Yue F; Zhou F
J Med Primatol; 2022 Dec; 51(6):355-366. PubMed ID: 35993379
[TBL] [Abstract][Full Text] [Related]
14. Metagenomics and Faecal Metabolomics Integrative Analysis towards the Impaired Glucose Regulation and Type 2 Diabetes in Uyghur-Related Omics.
Nuli R; Azhati J; Cai J; Kadeer A; Zhang B; Mohemaiti P
J Diabetes Res; 2019; 2019():2893041. PubMed ID: 31828159
[TBL] [Abstract][Full Text] [Related]
15. Distinctive Metabolomics Patterns Associated With Insulin Resistance and Type 2 Diabetes Mellitus.
Gu X; Al Dubayee M; Alshahrani A; Masood A; Benabdelkamel H; Zahra M; Li L; Abdel Rahman AM; Aljada A
Front Mol Biosci; 2020; 7():609806. PubMed ID: 33381523
[TBL] [Abstract][Full Text] [Related]
16. Serum untargeted metabolomics analysis of the mechanisms of evodiamine on type 2 diabetes mellitus model rats.
Yu Y; Lu Q; Chen F; Wang S; Niu C; Liao J; Wang H; Chen F
Food Funct; 2022 Jun; 13(12):6623-6635. PubMed ID: 35635367
[TBL] [Abstract][Full Text] [Related]
17. Importance of sulfur-containing metabolites in discriminating fecal extracts between normal and type-2 diabetic mice.
Walker A; Lucio M; Pfitzner B; Scheerer MF; Neschen S; de Angelis MH; Hartmann A; Schmitt-Kopplin P
J Proteome Res; 2014 Oct; 13(10):4220-31. PubMed ID: 24991707
[TBL] [Abstract][Full Text] [Related]
18. ENPP1 121Q functional variant enhances susceptibility to coronary artery disease in South Indian patients with type 2 diabetes mellitus.
Sumi S; Ramachandran S; RamanKutty V; Patel MM; Anand TN; Mullasari AS; Kartha CC
Mol Cell Biochem; 2017 Nov; 435(1-2):67-72. PubMed ID: 28497367
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive transcriptomics and metabolomics analyses reveal that hyperhomocysteinemia is a high risk factor for coronary artery disease in a chinese obese population aged 40-65: a prospective cross-sectional study.
Zhang CY; Xu RQ; Wang XQ; Sun LF; Mo P; Cai RJ; Lin XZ; Luo CF; Ou WC; Lu LJ; Zhong Y; Chen JY
Cardiovasc Diabetol; 2023 Aug; 22(1):219. PubMed ID: 37620823
[TBL] [Abstract][Full Text] [Related]
20. Untargeted serum metabolomics reveals Fu-Zhu-Jiang-Tang tablet and its optimal combination improve an impaired glucose and lipid metabolism in type II diabetic rats.
Tao Y; Chen X; Cai H; Li W; Cai B; Chai C; Di L; Shi L; Hu L
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():222-232. PubMed ID: 27866845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]